Clinical Trial Update: Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980 [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the pharmacokinetics and safety of a single intravenous infusion of BAY 79-4980 in Hemophilia A and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BAY 79-4980

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Phase 1 | Status: COMPLETED